The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Texas Oil Well Drilled

16 Apr 2012 07:00

RNS Number : 3551B
ViaLogy PLC
16 April 2012
 



SUCCESSFUL TEXAS OIL WELL DRILLED

USING VIALOGY ANALYSIS

 

London, Monday, April 16 2012 - ViaLogy PLC (LSE: VIY) announces today that its client Atascosa Exploration of San Antonio has successfully drilled another oil well at the Galba Field in South Central Texas using analysis provided by ViaLogy technology. This is the third commercially successful well Atascosa has drilled in the area using the new technology's recommended co-ordinates.

Under a 2009 contract with Atascosa, ViaLogy had mapped hydrocarbon reservoirs in the three upper Wilcox sandstone formations and provided multiple drilling locations targeting sands at varying depths in the field. Atascosa selected and drilled the new well in the Bartosh formation from its backlog of ViaLogy drilling locations. Oil was found at 3040 feet depth and with the predicted porosity values. Logging and sidewell core analyses have confirmed ViaLogy's predictive analysis and its determination of coordinates for the drilling site. Independent contractor Weatherford's core analysis showed 12 contiguous feet of net oil pay. Significantly, reservoir features were determined below the resolution of the 3-D seismic data using ViaLogy's processing which broadens the useable seismic spectra for both low and high frequencies by extracting and exploiting weak signal data normally discarded as noise.

Under its contract with Atascosa, ViaLogy will receive a 5% Back-In-After-Payout (BIAPO) working interest. This means that the Royalty will be paid on the net amount after drilling and production expenses have been covered.

Commenting on this latest well success Atascosa's Chief Executive, John Mullins, said: "We're very pleased with this drilling and its confirmation of ViaLogy predictions. Based on their recommendations we have increased our lease positions at the prospect. The accuracy of the predictions enabled us to secure approvals from the Texas Railroad Commission (TRRC) to drill additional offset wells at 10 acre spacings. This helps to maximise recovery, and to depart from the TRRC standard field rules that mandate 40 acre spacing between wells. It also ensures we get the best possible financial value from our leases."

 ViaLogy CEO Robert Dean said, "Atascosa was an early adopter of our technology and has been a great partner for us. Together we have been focused on discovering pockets of porosity and hydrocarbon in turbidites and sandstone laminates that are heavily faulted and compartmentalized. While hydrocarbon deposits in these areas may be small by supermajor standards, they are complex and similar in many respects to the much larger fields we are working in now. What's also really important is that they have given us the opportunity to exercise and stress our technology to find hydrocarbon reservoirs below the vertical resolution of 3-D seismic. QuantumRD's capability to characterize such hard-to-image formations and complex stratigraphy is something that is central to our current onshore and offshore projects with the large firms."

Robert Dean added, "We have made good progress in our discussions on new commercial services contracts for QuantumRD with O&G majors and should be able soon to comment publicly."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Katie Ratner, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner/David Banks, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLLLFEDSIIELIF
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.